GoHealth to be Delisted from Nasdaq on June 16 Following Bankruptcy Filing
GOCO is trading near its 52-week low of $0.287 (4.5% above the low) on elevated volume (7.4× avg).
Summary
GoHealth, Inc. received a final delisting notice from Nasdaq, with trading suspended on June 16, 2026, due to its Chapter 11 bankruptcy filing and failure to meet listing standards. The company does not intend to appeal, confirming the end of its Nasdaq listing.
Key Events · Corporate Governance and Compliance · GOCO
-
Nasdaq Delisting Confirmed
GoHealth received a final notice from Nasdaq to delist its Class A common stock, citing the Chapter 11 bankruptcy filing and public interest concerns, in addition to prior non-compliance with market value requirements.
-
Trading Suspension Date Set
Trading of GoHealth's Class A common stock on Nasdaq will be suspended at the opening of business on June 16, 2026.
-
No Appeal Intended
The company has stated it does not intend to appeal Nasdaq's delisting determination, making the delisting final.
-
Limited Shareholder Recovery Reiterated
The filing reiterates that existing equity holders (other than Series A redeemable convertible preferred stock) are expected to receive limited recovery under the prepackaged Chapter 11 plan.
Analysis · GOCO · Finance
This 8-K confirms the definitive delisting of GoHealth's Class A common stock from Nasdaq, effective June 16, 2026. The delisting is a direct consequence of the company's recent Chapter 11 bankruptcy filing and its failure to meet Nasdaq's continued listing requirements, including minimum market value. The company's decision not to appeal means existing shareholders will lose access to a major exchange, with trading potentially moving to less liquid over-the-counter markets, further diminishing any potential recovery for current equity holders as outlined in the bankruptcy plan.
At the time of this filing, GOCO was trading at $0.30 on NASDAQ in the Finance sector, with a market capitalization of approximately $9.2M. The 52-week trading range was $0.29 to $7.12. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.